Clearmind Medicine partners to develop intranasal MEAI for addiction & CNS disorders, boosting bioavailability & clinical progress.
Partnership established to improve absorption and aid in the progression of Clearmind's primary MEAI drug for addiction and other central nervous system conditions.
Source: Unusual Whales The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments